Teplizumab for Treatment of Type I Diabetes Mellitus

Saved in:
Bibliographic Details
Published in:The Annals of pharmacotherapy 2012-10, Vol.46 (10), p.1405-1412
Main Authors: SKELLEY, Jessica W, ELMORE, Lindsey K, KYLE, Jeffrey A
Format: Article
Language:English
Subjects:
Biological and medical sciences
Diabetes. Impaired glucose tolerance
Endocrine pancreas. Apud cells (diseases)
Endocrinopathies
Etiopathogenesis. Screening. Investigations. Target tissue resistance
Medical sciences
Pharmacology. Drug treatments
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by
cites
container_end_page 1412
container_issue 10
container_start_page 1405
container_title The Annals of pharmacotherapy
container_volume 46
creator SKELLEY, Jessica W
ELMORE, Lindsey K
KYLE, Jeffrey A
description
doi_str_mv 10.1345/aph.1R065
format article
fullrecord <record><control><sourceid>pascalfrancis</sourceid><recordid>TN_cdi_pascalfrancis_primary_26470931</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>26470931</sourcerecordid><originalsourceid>FETCH-LOGICAL-p115t-4bf2506a611f31bd0fa6d2b7e0d8d18d33b42ffcdbefa6737af49f1cdf6925303</originalsourceid><addsrcrecordid>eNotjMtKw0AUQAdRsFYX_sFsXKbeO68kS6mvQqVQ4rrcyczFSNIOmXRRv96Crs6BA0eIe4QFamMfKX0tcAvOXogZWqMKp0q4PDs4KEBVcC1ucv4GgBpVPROmianvfo4DecmHUTZjpGmI-0keWDanFOVKPnfk4xSz_Ih9303HfCuumPoc7_45F5-vL83yvVhv3lbLp3WREO1UGM_KgiOHyBp9ACYXlC8jhCpgFbT2RjG3wcdzKXVJbGrGNrCrldWg5-Lh75sot9TzSPu2y7s0dgONp51ypoRao_4FdfJHPA</addsrcrecordid><sourcetype>Index Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype></control><display><type>article</type><title>Teplizumab for Treatment of Type I Diabetes Mellitus</title><source>SAGE:Jisc Collections:SAGE Journals Read and Publish 2023-2024:2025 extension (reading list)</source><creator>SKELLEY, Jessica W ; ELMORE, Lindsey K ; KYLE, Jeffrey A</creator><creatorcontrib>SKELLEY, Jessica W ; ELMORE, Lindsey K ; KYLE, Jeffrey A</creatorcontrib><identifier>ISSN: 1060-0280</identifier><identifier>EISSN: 1542-6270</identifier><identifier>DOI: 10.1345/aph.1R065</identifier><identifier>CODEN: APHRER</identifier><language>eng</language><publisher>Cincinnati, OH: Whitney</publisher><subject>Biological and medical sciences ; Diabetes. Impaired glucose tolerance ; Endocrine pancreas. Apud cells (diseases) ; Endocrinopathies ; Etiopathogenesis. Screening. Investigations. Target tissue resistance ; Medical sciences ; Pharmacology. Drug treatments</subject><ispartof>The Annals of pharmacotherapy, 2012-10, Vol.46 (10), p.1405-1412</ispartof><rights>2015 INIST-CNRS</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,776,780,27901,27902</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&amp;idt=26470931$$DView record in Pascal Francis$$Hfree_for_read</backlink></links><search><creatorcontrib>SKELLEY, Jessica W</creatorcontrib><creatorcontrib>ELMORE, Lindsey K</creatorcontrib><creatorcontrib>KYLE, Jeffrey A</creatorcontrib><title>Teplizumab for Treatment of Type I Diabetes Mellitus</title><title>The Annals of pharmacotherapy</title><subject>Biological and medical sciences</subject><subject>Diabetes. Impaired glucose tolerance</subject><subject>Endocrine pancreas. Apud cells (diseases)</subject><subject>Endocrinopathies</subject><subject>Etiopathogenesis. Screening. Investigations. Target tissue resistance</subject><subject>Medical sciences</subject><subject>Pharmacology. Drug treatments</subject><issn>1060-0280</issn><issn>1542-6270</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2012</creationdate><recordtype>article</recordtype><recordid>eNotjMtKw0AUQAdRsFYX_sFsXKbeO68kS6mvQqVQ4rrcyczFSNIOmXRRv96Crs6BA0eIe4QFamMfKX0tcAvOXogZWqMKp0q4PDs4KEBVcC1ucv4GgBpVPROmianvfo4DecmHUTZjpGmI-0keWDanFOVKPnfk4xSz_Ih9303HfCuumPoc7_45F5-vL83yvVhv3lbLp3WREO1UGM_KgiOHyBp9ACYXlC8jhCpgFbT2RjG3wcdzKXVJbGrGNrCrldWg5-Lh75sot9TzSPu2y7s0dgONp51ypoRao_4FdfJHPA</recordid><startdate>20121001</startdate><enddate>20121001</enddate><creator>SKELLEY, Jessica W</creator><creator>ELMORE, Lindsey K</creator><creator>KYLE, Jeffrey A</creator><general>Whitney</general><scope>IQODW</scope></search><sort><creationdate>20121001</creationdate><title>Teplizumab for Treatment of Type I Diabetes Mellitus</title><author>SKELLEY, Jessica W ; ELMORE, Lindsey K ; KYLE, Jeffrey A</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-p115t-4bf2506a611f31bd0fa6d2b7e0d8d18d33b42ffcdbefa6737af49f1cdf6925303</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2012</creationdate><topic>Biological and medical sciences</topic><topic>Diabetes. Impaired glucose tolerance</topic><topic>Endocrine pancreas. Apud cells (diseases)</topic><topic>Endocrinopathies</topic><topic>Etiopathogenesis. Screening. Investigations. Target tissue resistance</topic><topic>Medical sciences</topic><topic>Pharmacology. Drug treatments</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>SKELLEY, Jessica W</creatorcontrib><creatorcontrib>ELMORE, Lindsey K</creatorcontrib><creatorcontrib>KYLE, Jeffrey A</creatorcontrib><collection>Pascal-Francis</collection><jtitle>The Annals of pharmacotherapy</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>SKELLEY, Jessica W</au><au>ELMORE, Lindsey K</au><au>KYLE, Jeffrey A</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Teplizumab for Treatment of Type I Diabetes Mellitus</atitle><jtitle>The Annals of pharmacotherapy</jtitle><date>2012-10-01</date><risdate>2012</risdate><volume>46</volume><issue>10</issue><spage>1405</spage><epage>1412</epage><pages>1405-1412</pages><issn>1060-0280</issn><eissn>1542-6270</eissn><coden>APHRER</coden><cop>Cincinnati, OH</cop><pub>Whitney</pub><doi>10.1345/aph.1R065</doi><tpages>8</tpages></addata></record>
fulltext fulltext
identifier ISSN: 1060-0280
ispartof The Annals of pharmacotherapy, 2012-10, Vol.46 (10), p.1405-1412
issn 1060-0280
1542-6270
language eng
recordid cdi_pascalfrancis_primary_26470931
source SAGE:Jisc Collections:SAGE Journals Read and Publish 2023-2024:2025 extension (reading list)
subjects Biological and medical sciences
Diabetes. Impaired glucose tolerance
Endocrine pancreas. Apud cells (diseases)
Endocrinopathies
Etiopathogenesis. Screening. Investigations. Target tissue resistance
Medical sciences
Pharmacology. Drug treatments
title Teplizumab for Treatment of Type I Diabetes Mellitus
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-05T09%3A41%3A57IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-pascalfrancis&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Teplizumab%20for%20Treatment%20of%20Type%20I%20Diabetes%20Mellitus&rft.jtitle=The%20Annals%20of%20pharmacotherapy&rft.au=SKELLEY,%20Jessica%20W&rft.date=2012-10-01&rft.volume=46&rft.issue=10&rft.spage=1405&rft.epage=1412&rft.pages=1405-1412&rft.issn=1060-0280&rft.eissn=1542-6270&rft.coden=APHRER&rft_id=info:doi/10.1345/aph.1R065&rft_dat=%3Cpascalfrancis%3E26470931%3C/pascalfrancis%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-p115t-4bf2506a611f31bd0fa6d2b7e0d8d18d33b42ffcdbefa6737af49f1cdf6925303%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true